Muhammad Awidi: Can Jordan’s Health System Survive The Smoking Epidemic
Muhammad Awidi/ LinkedIn

Muhammad Awidi: Can Jordan’s Health System Survive The Smoking Epidemic

Muhammad Awidi, Hematology and Oncology Fellow at Roswell Park Cancer Center, shared on LinkedIn:

“Can Jordan’s health system survive the smoking epidemic?

I was invited to speak at The Alliance of Jordanian Universities against Tobacco and Smoking a few days ago. I posed that exact question to them.

The short answer is No. And the ‘why’ should be an economic and clinical wake-up call.

The hard facts:

  • We are mortgaging our youth. 50% of Jordanians are under the age of 20. Yet, 34% of teens are already smokers. We aren’t even seeing the full ‘health bill’ for this yet but it’s coming.
  •  The ‘Cheap’ Trap. Tobacco taxes are around 75%, yet a pack remains among the most affordable in the region. It’s too easy to start and too cheap to stay addicted.
  •  The Math Doesn’t Add Up.
    Cost to the economy: $2.1 Billion
    Tax revenue: $1.4 Billion
    Net loss: $700 Million every single year.
  •  With the health budget stagnant at ~6% of GDP, we simply don’t have the infrastructure to handle the surge in chronic disease coming in the next 10 years.

The Solution?
A Sovereign Health Fund
This must be constitutionally protected from being ‘borrowed’ by other departments or reallocated. We need a system that actually accounts for the high cost of care and loss of productivity

  • Tobacco Companies: A mandatory CSR contribution of 5–7% of profits.
  • The Consumer: A dynamic ‘health premium’ of 0.2–0.5 JOD per pack at the point of purchase.

Most importantly, we need to treat the addiction, not just the eventual disease by funding a National Cessation Clinics network with real incentives for patients.

It’s time to stop viewing tobacco as a revenue stream and start seeing it for what it is: a national health debt we can no longer afford to ignore.”

Muhammad Awidi: Can Jordan’s Health System Survive The Smoking Epidemic

Other Articles Featuring Muhammad Awidi on OncoDaily.